Jump Financial, LLC Prelude Therapeutics Inc Transaction History

Jump Financial, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$2.07 - $6.37 $32,155 - $98,951	15,534 New	15,534 $32,000
Q1 2022 May 12, 2022	SELL	$6.9 - $13.22 $254,610 - $487,818	-36,900 Closed	0 $0
Q4 2021 Feb 10, 2022	BUY	$11.89 - $31.74 $438,741 - $1.17 Million	36,900 New	36,900 $459,000
Q3 2021 Nov 12, 2021	SELL	$25.78 - $38.65 $353,186 - $529,505	-13,700 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$28.63 - $44.3 $211,862 - $327,820	7,400 Added 117.46%	13,700 $392,000
Q1 2021 May 17, 2021	BUY	$39.27 - $91.68 $247,401 - $577,584	6,300 New	6,300 $273,000

30.4M

6.4K

Ticker PRLD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,369,200
Market Cap $31.6M
Description
Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT543 that is in Phase 1 clinical trials in select solid tumors and myeloid malignancies; and PRT811, which is in Phase 1 clinical trials in solid ...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.